Somatic cell hybrids between human lymphoma lines. III. Surface markers.
Hybrids between two human lymphoma lines, Raji and Daudi (8A) and Raji BJAB (83) were examined for genetically determined and/or differentiation-related surface markers. HL-A B ce-l alloantigens, Fc and complement receptors, EBV receptors and beta2 microglobulin showed an autonomous ("co-dominant") expression in the hybrid. This is in contrast to most previous studies on other differentiation markers, involving as a rule crosses between cells of different lineages, where the differentiated pattern usually became "eclipsed" in the hybrid. Staining of activated complement and complement consumption tests showed intermediate or partially suppressed expression in the hybrids. This may be viewed in relation to the fact that these reactions do not merely depend on complement binding to the receptor, but also on subsequent activation and binding of the activated complement. A more complex interaction is also suggested for immunoglobulin production. Surface immunoglobulin showed a suppressive or intermediate pattern in both hybrids, whereas intracellular kappa chain production showed an amplification in the 83 hybrid. The beta2 microglobulin deficiency of the Daudi parent was corrected in the Raji/Daudi hybrid. Two new HL-A specificities,A10 and BW17, appeared on this hybrid which were not present on the parental lines. This suggests that the HL-A deficiency of the Daudi cell is due to its lack of beta2 microglobulin.
D001402:B-Lymphocytes / Q000276:immunology; D001666:Binding Sites, Antibody; D002460:Cell Line; D003176:Complement C3 / Q000032:analysis; D003168:Complement Fixation Tests; D003165:Complement System Proteins / Q000032:analysis; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D006822:Hybrid Cells / Q000276:immunology*; D007126:Immunoglobulin Allotypes; D007141:Immunoglobulin Fc Fragments / Q000032:analysis; D007519:Isoantigens / Q000032:analysis; D008223:Lymphoma / Q000276:immunology*; D011947:Receptors, Antigen, B-Cell / Q000032:analysis; D001613:beta 2-Microglobulin / Q000276:immunology
D003176:Complement C3; D006680:HLA Antigens; D007126:Immunoglobulin Allotypes; D007141:Immunoglobulin Fc Fragments; D007519:Isoantigens; D011947:Receptors, Antigen, B-Cell; D001613:beta 2-Microglobulin; D003165:Complement System Proteins